DIREXION SHS ETF TR LABD
DAILY S&P BIOTEC · ETP · CUSIP 25460G716
0
institutional holders
-19 vs Q2 2025
—reported value*
0 new
0 added
0 reduced
18 sold out
net sold ≈ $9.5m (-1.3m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q3 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 19 |
| Q4 2022 | 17 |
| Q1 2023 | 18 |
| Q2 2023 | 21 |
| Q3 2023 | 18 |
| Q4 2023 | 20 |
| Q1 2024 | 22 |
| Q2 2024 | 18 |
| Q3 2024 | 16 |
| Q4 2024 | 19 |
| Q1 2025 | 16 |
| Q2 2025 | 19 |
| Q3 2025 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2023 | 13 | 7 |
| Q1 2024 | 13 | 12 |
| Q2 2024 | 8 | 14 |
| Q3 2024 | 8 | 11 |
| Q4 2024 | 10 | 9 |
| Q1 2025 | 10 | 13 |
| Q2 2025 | 12 | 8 |
| Q3 2025 | 0 | 18 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
CallsPuts
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q4 2024 | $7.7m | $1.0m | 0.14 |
| Q1 2025 | $9.6m | $1.4m | 0.15 |
| Q2 2025 | $11.5m | $2.0m | 0.17 |
| Q3 2025 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| JANE STREET GROUP, LLC | Sold out | -336.9k |
| Virtu Financial LLC | Sold out | -259.9k |
| CITADEL ADVISORS LLC | Sold out | -212.1k |
| Jump Financial, LLC | Sold out | -174.2k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Sold out | -54.0k |
| GOLDMAN SACHS GROUP INC | Sold out | -52.4k |
| GROUP ONE TRADING LLC | Sold out | -45.1k |
| HRT FINANCIAL LP | Sold out | -41.7k |
| Tower Research Capital LLC (TRC) | Sold out | -41.2k |
| GTS SECURITIES LLC | Sold out | -20.3k |
Holders, Q3 2025
| Manager | Shares | Change |
|---|